OYO IPO News | Shyam IPO & Gujarat Kidney IPO Final Decision - GMP मे बम्पर तेज़ी - Apply or not ?

OYO Hotels IPO is approved – will shareholder quota be available or not? Clear answer inside.
This video also gives final decision on Gujarat Kidney IPO and Shyam Industries IPO.
________

📲 Join Telegram For All IPO update :- https://t.me/Ankursinghji1
_______

▶️ Watch Video: 🎥 👇

1. How to Buy & Sell IPO in Pre Open Market Step by Step 👇
https://youtu.be/JAJ00_KKYsA

2. 2 Big Upcoming Shareholders Quota IPO all important Details 👇
https://youtu.be/9OVDvIJIYzk

3. Upcoming IPOs in Dec & January 2026 👇
https://youtu.be/HIqoCCUcL00?si=XekIuiyntSVg_sc0

4. 23 Upcoming IPOs in December 👉 https://youtu.be/ZD19AiV6Z28

5. 7+ Upcoming IPO With Shareholder Quota only 👉 https://youtu.be/LJYj_WDjW5s

=====================================

📊 COVERED IN VIDEO - :
Today’s video covers OYO Hotels IPO approval, including whether shareholder quota will be available, how record date works, and what investors should realistically expect. Along with this, we also discuss Gujarat Kidney IPO and Shyam Industries IPO with a clear final decision so you get a complete understanding in one place.
(No “buy”, “sell”, Recommendations . – pure analysis only)

=====================================

⚠️ DISCLAIMER
This content is only for educational purposes.
It does not include any investment instructions or guaranteed results.
IPO pricing, GMP and listing outcomes can change based on market conditions. Always verify information and consult a licensed advisor before taking any action.

=====================================

🔥 HASHTAGS
#upcomingipo #ankursingh #newipoupdate #IPOGMP #IPOGMPToday #LatestIPOGMP #LatestIPONews #OYOHotelsIPO
#ShareholderQuotaipo
#IPOgmptoday
#GujaratKidneyIPO
#ShyamIndustriesIPO
#iposubscription
#ipoupdate
#IPOIndia
#IPOAnalysis
#IPOEducation
#AnkurSingh
#oyohotelipo
#oyoiop

=====================================

📌 Subscribe & Support ❤️
If you like honest and research-based IPO reviews without hype, make sure to subscribe and share this video. Your support helps the content stay independent and useful.